Mustang Bio Inc reports results for the quarter ended in September - Earnings Summary

Mustang Bio

14/11/2022 21:55

* Mustang Bio Inc  MBIO.OQ  reported a quarterly adjusted
loss
of 18 cents​​ per share for the quarter ended in September. The
mean expectation of five analysts for the quarter was for a loss
of 20 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Mustang Bio Inc's reported EPS for the quarter was a loss
of 18
cents​.
    * The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Mustang Bio Inc shares had risen by 0.7% this quarter and
lost 71.5% so far this year.
    * The company reported a quarterly loss of $19 million.
    * Wall Street's median 12-month price target for Mustang Bio
Inc
is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 09:54 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.20          -0.18          Beat
 Jun. 30 2022      -0.21          -0.19          Beat
 Mar. 31 2022      -0.18          -0.20          Missed
 Dec. 31 2021      -0.19          -0.22          Missed